Cite Filings / DNTH / 0000902219-26-000166

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Dianthus Therapeutics, Inc. /DE/ Filed 2026-05-15 Acc 0000902219-26-000166

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-05-22 4 Options or other derivatives
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-11 4 Director sold 599 shares at $85.47 ($51,197)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…